W. R. Berkley (NYSE: WRB) Q3 2026 Earnings: Mixed Results for the Insurance Giant

Font: Financial Modeling Prep  • Oct 19, 2026

• W. R. Berkley (NYSE: WRB) reported mixed Q3 2026 financial results, with earnings per share exceeding estimates but revenue falling short.
• The insurance company demonstrated positive premium growth, with gross premiums written increasing 3% and net premiums written rising 1% for the quarter.
• Despite the earnings beat, net income saw a decline, while key valuation metrics like P/E and P/S ratios offer insights into the stock's current market position.

The stock of W. R. Berkley (NYSE: WRB) represents a prominent insurer that specializes in selling commercial insurance and reinsurance. For its third-quarter 2026, the company announced earnings per share of $1.17, which surpassed the analyst estimate of $1.15. However, revenue came in at $3.74 billion, falling below the projected $3.82 billion. Earnings per share, a key indicator of profitability, reflect the profit attributable to each common share.

Premium growth provides more context for these mixed financial results. Gross premiums written, which represent the total value of policies sold before sharing risk with other insurers, saw a rise of 3% from a year earlier, reaching $3.95 billion. Net premiums written, which exclude premiums passed to those insurers, increased by 1% to $3.27 billion, as highlighted by Business Wire, indicating steady growth in the insurance sector.

Despite the positive earnings-per-share beat, net income available to common stockholders experienced a decline of 13%, falling to $446 million from $511 million in the prior year. Over the first nine months of 2026, gross premiums written for W. R. Berkley increased 3% to $11.88 billion, while net premiums written rose 2% to $9.87 billion, showcasing consistent performance in the insurance market.

W. R. Berkley currently trades at a trailing price-to-earnings ratio of 15.2, meaning its share price is 15.2 times its earnings over the past year. Its price-to-sales ratio and enterprise value-to-sales ratio are both 1.5. Furthermore, its enterprise value-to-operating cash flow ratio stands at 7.6, and its trailing earnings yield is 6.7%. These valuation metrics are crucial for investment analysis.